US equities |
NVDA $239.24 ▲+0.14% MU $1,045.56 ▼-1.73% SPCX $171.92 ▲+0.49% AMD $649.42 ▲+2.80% MRVL $287.01 ▲+5.81% AVGO $375.81 ▲+3.67% INTC $112.50 ▼-3.18% MSFT $529.30 ▲+0.78%
FinancialContent

Latest News about Blood Cancer

Recent news which mentions Blood Cancer

AstraZeneca Says Calquence/Chemo Combo Data Shows Additional 16.8 Months Without Disease Progression In Patients With Certain Type Of Blood Cancer
Tickers AZN NEWS
Tags blood cancer General Large Cap
From Benzinga
House Majority Leader Steve Scalise Diagnosed With Treatable Blood Cancer
Tickers GOP
Tags Politics Market News News
From Benzinga
Five clinical trials impacting blood cancers approved for funding
Tags Science Cancer Illinois
From PRLog
Overcoming Blood Cancer With CAR T-cell Therapy: Eleonora's Journey
Tags NYSE:GILD non/Hodgkin lymphoma Health & Healthcare
From 3BL Media: Corporate Social Responsibility, Energy and Health News
Gilead Withdraws Use Of Zydelig In Two Forms Of Blood Cancer In US
Tickers GILD
Tags Benzinga Biotech General
From Benzinga
IDI Consulting Supports the Leukemia & Lymphoma Society's Light The Night Walk
Tags Medical Lymphoma Leukemia
From PRLog
Takeda's Breakthrough Blood Cancer Drug Flunks In Phase 3 Study
Tickers TAK TKPHF
Tags Benzinga TAK Biotech
From Benzinga
Pfizer Beefs Up Blood Cancer Pipeline With Trillium Acquisition: See Highlights
Tickers PFE TRIL
Tags Health Care Briefs Small Cap
From Benzinga
BeiGene's Brukinsa Prolongs Progression-Free Survival Compared To Chemo In Untreated Blood Cancer Patients
Tickers BGNE
Tags Biotech Benzinga blood cancer
From Benzinga
Magenta Therapeutics Stock Drops As FDA Issues Clinical Hold On Blood Cancer Candidate IND
Tickers MGTA
Tags FDA MGTA News
From Benzinga